FDA 483 - Amcor Flexibles, LLC. - September 14, 2017

An FDA inspection of Amcor Flexibles, a medical device manufacturer in Commerce, California, identified a significant quality system deficiency. The firm failed to adequately document the monitoring and verification of the effectiveness checks for its corrective and preventive actions (CAPA). This indicates a breakdown in ensuring the long-term efficacy of implemented quality improvements.